2017
DOI: 10.1111/myc.12630
|View full text |Cite
|
Sign up to set email alerts
|

Endomyocardial and pericardial aspergillosis in critically ill patients

Abstract: Invasive aspergillosis(IA) is a potentially lethal complication of Aspergillus infection affecting mainly immunocompromised hosts; however, during the last two decades its incidence was increasingly observed in critically ill immunocompetent patients. The objective of this study is to describe the clinical characteristics of histologically proven endomyocardial and pericardial invasion, in the context of IA, in critically ill patients. Eight critically ill patients with histopathological confirmation of endomy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 31 publications
(48 reference statements)
0
2
0
Order By: Relevance
“…Pericardial aspergillus can be due to either the mycotic emboli spreading hematogenously or directly from an infected endocardium. [7] Therefore, culture of the valve vegetation and blood are required to detect the source of infection. Besides, infective endocarditis with valve regurgitation is more likely due to a known rheumatic heart disease.…”
Section: Discussionmentioning
confidence: 99%
“…Pericardial aspergillus can be due to either the mycotic emboli spreading hematogenously or directly from an infected endocardium. [7] Therefore, culture of the valve vegetation and blood are required to detect the source of infection. Besides, infective endocarditis with valve regurgitation is more likely due to a known rheumatic heart disease.…”
Section: Discussionmentioning
confidence: 99%
“…3,4 Although non-valvular cardiac aspergillosis has a predilection for the immunocompromised, cases have been reported in young immunocompetent patients, frequently with fatal consequences. 5,6 There is a paucity of reports of non-valvular cardiac aspergillosis in solid organ transplant (SOT) and immunocompetent individuals. The majority of cases have been reported in haemato-oncology patients.…”
Section: Introductionmentioning
confidence: 99%